Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a reduced intensity (RI) (non-myeloablative)
chemoimmunotherapy followed by Allogeneic Stem Cell Transplantation AlloSCT (matched family
donors and matched unrelated cord blood donors) will be well tolerated.